Johnson & Johnson

The study was based on a US health database, and so did not accrue new data on the risk of clots from AstraZeneca's vaccine…

Following the news that the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)…

The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays…

FDA acting commissioner Janet Woodcock said it expected the pause to be a matter of days, and it was aimed at providing…

India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme

The vaccine candidate will initially be tested in a small number of adolescents aged 16-17 years

Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10…

It had previously said it was developing a second-generation vaccine that would target the variant first identified in South…

Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including…

If granted conditional marketing authorisation by the EC, the J&J single-shot COVID-19 vaccine will be available in the EU